Clinical Information System Impact on Hospitalized Patients With Chronic Disease (NCT07609381) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Clinical Information System Impact on Hospitalized Patients With Chronic Disease
Canada124,240 participantsStarted 2026-06-01
Plain-language summary
This is a retrospective, observational study using routinely collected information collected by Alberta Health Services. The study will identify patients with chronic disease, defined by one or more of the following conditions; diabetes mellitus, heart failure, coronary artery disease, chronic kidney disease, or chronic lung disease. Adult residents of Alberta with a chronic disease of interest present upon hospital admission and who survive to hospital discharge will be included in the study cohort. The primary outcome will be the composite of hospital readmission or death within 30 days of discharge. Secondary outcomes will include components of the composite, length of stay, patient experiences related to their hospital to home transition of care, and processes of care. Multi-level interrupted time series analysis will be used to compare outcomes before versus after implementation of the Connect Care CIS.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older at the time of hospital admission.
* Residents of Alberta eligible to receive acute-care services in AHS facilities.
* Hospitalized for any cause during the study period (5 years pre-implementation and 2 years post-implementation of the CIS).
* Meet the validated case definition for one or more of the five key NCDs (diabetes mellitus, chronic kidney disease, coronary artery disease, heart failure, or chronic lung disease) based on ICD codes, laboratory measures, or pharmacy records during standardized lookback periods (up to 5 years for diagnoses; up to 1 year for labs/pharmacy).
* Have a qualifying date for the NCD(s) that occurs prior to or during the index hospital admission.
* Eligible for inclusion in the primary and patient experience outcomes if they survive to hospital discharge.
* May enter multiple sub-cohorts if more than one NCD is present.
Exclusion Criteria:
* Individuals younger than 18 years at the time of hospital admission.
* Non-residents of Alberta or individuals not eligible for care within AHS facilities.
* Hospitalizations that end in death (excluded from analyses of the primary outcome and patient experience measures).
* Patients without evidence of any of the five key NCDs during the lookback period or at the index hospital admission.
* Admissions outside the study period or admissions for which necessary administrative, laboratory, or pharmacy data are unavailable.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
All-cause unplanned hospital readmission or death within 30 days after hospital discharge
Timeframe: Within 30 days after hospital discharge